Effects of Social Media Use on Young Adults' E-Cigarette Use

NCT ID: NCT06142877

Last Updated: 2024-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-04

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to test the effects of social media use on e-cigarette use in young adults who use e-cigarettes. The main questions it aims to answer are:

* Does reducing social media use change young adults' e-cigarette use?
* Does reducing social media use change things such as young adults' mental health and what they see on social media?

Participants will complete surveys and submit screenshots showing how much time they spend on social media.

Researchers will compare young adults who reduce their social media use to young adults who use social media as usual, to see if their e-cigarette use differs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The overall goals of this project are to understand how young adults' social media use affects their nicotine vaping and to identify intervention targets that mitigate social media's impact on vaping. Prevalence of vaping and social media use among young adults have increased in tandem. Exposure to vaping-related social media content is common and is associated with vaping. Intense social media use appears to contribute to young adults' increased mental health symptoms, which are linked to tobacco product use. This project aims to contribute to scientific understanding of the causal links between social media use and vaping in young adulthood. Young adults with past-month vaping will report time spent on social media, vaping-related social media content exposure, social comparison on social media, mental health, and vaping behavior. After a 1-month baseline measurement period, they will be randomized to reduce their social media use (incentivized) or use social media as usual for a 3-month experimental period. Longitudinal within- and between-subjects analyses will test relationships between time spent on social media, risk factors for vaping, and vaping behavior. Specific research aims are to: (1) investigate the relationships between a reduction in social media use and: a) vaping content exposure, b) social comparison, and c) mental health, and (2) examine whether reducing social media use reduces past-month vaping days, vaping episodes per vaping day, and puffs per vaping episode.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Electronic Cigarette Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomized to one of two groups: 1) social media use reduction (intervention), or 2) social media use as usual (control).
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Social Media Use Reduction

Group Type EXPERIMENTAL

Social Media Use Reduction

Intervention Type BEHAVIORAL

Participants will be incentivized to reduce their social media use by a pre-specified percentage from baseline.

Social Media Use as Usual

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Social Media Use Reduction

Participants will be incentivized to reduce their social media use by a pre-specified percentage from baseline.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-25
* Daily social media use
* Ownership of a smartphone
* Vaping (i.e., use of a nicotine e-cigarette) on 1-19 days of the past 30 days
* Residing in the United States

Exclusion Criteria

-Lack of capacity to provide informed consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role collaborator

University of Southern California

OTHER

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role collaborator

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

University of Oklahoma

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Erin A Vogel, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Oklahoma

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Erin A Vogel, PhD

Role: CONTACT

405-271-8001 ext. 50493

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Erin A Vogel, PhD

Role: primary

405-271-8001 ext. 50493

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K01DA055073

Identifier Type: NIH

Identifier Source: secondary_id

View Link

15427

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of Aversive Warnings on E-Cigarette Cessation
NCT05892445 NOT_YET_RECRUITING PHASE3
Effective Ads for Quitting Smoking
NCT06485479 COMPLETED NA
Network Intervention to Prevent Vaping
NCT04678245 ACTIVE_NOT_RECRUITING NA